fbpx
May 22, 2020

FDA OKs Apomorphine Sublingual Film for ‘Off’ Episodes in PD FDA OKs Apomorphine Sublingual Film for ‘Off’ Episodes in PD

The US Food and Drug Administration (FDA) has approved apomorphine hydrochloride sublingual film (Kynmobi, Sunovion) for the acute, intermittent treatment of ‘off’ episodes in patients with […]
May 20, 2020

FDA Approves Olaparib for Certain Metastatic Prostate Cancers FDA Approves Olaparib for Certain Metastatic Prostate Cancers

The US Food and Drug Administration approved olaparib (Lynparza, AstraZeneca) for deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate […]
May 19, 2020

First PARP Inhibitor Approved for Metastatic Prostate Cancer First PARP Inhibitor Approved for Metastatic Prostate Cancer

A completely new approach to the treatment of prostate cancer is now available to clinicians through the approval of the first PARP inhibitor for use in […]
May 15, 2020

FDA Issues Alert on Accuracy of Abbott ID NOW Rapid Test FDA Issues Alert on Accuracy of Abbott ID NOW Rapid Test

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Preliminary data suggest that Abbott Labs’ ID NOW rapid test for COVID-19, […]
May 15, 2020

FDA Approves Pomalidomide for Kaposi Sarcoma FDA Approves Pomalidomide for Kaposi Sarcoma

The US Food and Drug Administration (FDA) has granted accelerated approval to pomalidomide (Pomalyst, Bristol-Myers Squibb) for the treatment of AIDS-related Kaposi sarcoma that is resistant […]
May 12, 2020

Class I Recall for Applied Medical’s Embolectomy Catheters Class I Recall for Applied Medical’s Embolectomy Catheters

Applied Medical is recalling 19,400 of their Python embolectomy catheters, Bard embolectomy catheters, and OTW Latis cleaning catheters because the catheter tip could detach during use. […]
May 11, 2020

FDA Approves Selpercatinib for Lung and Thyroid RET Tumors FDA Approves Selpercatinib for Lung and Thyroid RET Tumors

Selpercatinib (Retevmo, Loxo/Lilly) becomes the first targeted therapy to be approved by the US Food and Drug Administration (FDA) for use in patients with cancer who […]
May 8, 2020

FDA OKs New Aspire MAX Mechanical Thrombectomy System FDA OKs New Aspire MAX Mechanical Thrombectomy System

The US Food and Drug Administration (FDA) has approved the Aspire MAX 7–11F mechanical thrombectomy system to remove blood clots from peripheral vessels, Control Medical Technology, […]
May 7, 2020

Community Cancer Practices Battered by Closures, Now COVID-19 Community Cancer Practices Battered by Closures, Now COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The past decade has seen a trend in community oncology clinics and […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0